Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

31 déc. 2024 07h00 HE | Source: Nutriband Inc.

Nutriband Issues Letter to Shareholders

CEO Publishes Letter to Shareholders looking over achievements in 2024 and outlook for 2025
27 déc. 2024 09h25 HE | Source: Nutriband Inc.

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Chinese Patent for AVERSA extended to Macao
04 déc. 2024 09h00 HE | Source: Nutriband Inc.

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Nutriband Inc. Q3 report and highlights
04 déc. 2024 07h00 HE | Source: Nutriband Inc.

Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

Serguei Melnik will present at the Noble Conference to discuss the companies latest advances with its AVERSA technology
27 nov. 2024 07h00 HE | Source: Nutriband Inc.

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Nutriband Inc receives Hong Kong Patent Notice of Publication for its AVERSA patent application bringing the total number of countries covered to 46